Our resource library is a searchable collection of documents, tools, and resources on achieving sustainable and equitable immunisation programmes. You can filter the resources by topic, type, or country.


Results 1 -10 of 15

LNCT Webinar: Lessons Learned from Sri Lanka’s Transition from Gavi Support


Learning about Sri Lanka’s experience transitioning from Gavi support.


As your country prepares to transition away from Gavi support, learn from Sri Lanka’s experiences, including successes and challenges, with securing domestic financing, strengthening local capacity, and introducing new vaccines.


Sri Lanka’s national immunization program is cited globally and regionally as a successful model.


DPT3 Vaccine Coverage in Africa Data Visualization

This interactive data visualization maps DPT3 vaccine coverage in African nations in fine-scale, 5×5 kilometer increments, so that health officials nationally and locally can identify gaps in vaccine coverage and target interventions with precision, tailoring health policy decisions at local levels. This visualization was developed as part of the Mapping diphtheria-pertussis-tetanus vaccine coverage in Africa, 2000-2016: a spatial and temporal modelling study,


Mapping Diphtheria-Pertussis-Tetanus Vaccine Coverage in Africa, 2000–2016: A Spatial and Temporal Modelling Study

Routine childhood vaccination is among the most cost-effective, successful public health interventions available. Amid substantial investments to expand vaccine delivery throughout Africa and strengthen administrative reporting systems, most countries still require robust measures of local routine vaccine coverage and changes in geographical inequalities over time.

This analysis drew from 183 surveys done between 2000 and 2016,


Human Papillomavirus Vaccine Introduction in South Africa: Implementation Lessons From an Evaluation of the National School-Based Vaccination Campaign

In April 2014, a national school-based human papillomavirus (HPV) vaccination program was rolled out in South Africa, targeting Grade 4 girls aged ≥9 years. A bivalent HPV vaccine with a 2-dose (6 months apart) schedule was used. At the request of the National Department of Health (NDoH), an external assessment of the first-dose phase of the vaccination program was conducted to evaluate program coverage and vaccine safety and identify factors that influenced implementation.


The Role of National Immunisation Technical Advisory Groups (NITAGs) in Strengthening National Vaccine Decision-making: A Comparative Case Study of Armenia, Ghana, Indonesia, Nigeria, Senegal and Uganda

Improving evidence informed decision-making in immunization is a global health priority and many low and middle-income countries have established National Immunization Technical Advisory Groups (NITAGs) as independent technical advisory bodies for this purpose. NITAG development and strengthening has received financial and technical support over the past decade, but relatively little evaluation.


NITAG Resource Center

The NITAG Resource Center provides essential documents needed for NITAG establishment, strengthening, and evaluation. Use the interactive map to see each country’s NITAG status, the media center to easily search for guidelines, reports, training, or scientific publications, and the news and events to explore upcoming events relevant for NITAG members.

The platform  was created AMP’s Health Policy and Institutional Development (HPID) unit—which was designated a World Health Organization Collaborating Centre (WHO CC) for evidence-informed immunization policy-making.


WHO/UNICEF Estimates of National Immunization Coverage

WHO and UNICEF reviewed available data submitted to the organizations and grey papers to make individual country estimates of immunization coverage.

Estimates were made for BCG, the first and third doses of diphtheria and tetanus toxoid and pertussis containing vaccine (DTP1 and DTP3), the third dose of polio containing vaccine – either oral polio vaccine or inactivated polio vaccine (Pol3) –


WHO Immunization Schedules Database by Country

The WHO’s Immunization schedule selection center is a searchable database of global, regional, and national summaries on vaccine application. Each page includes information a description of the vaccine, antigens, ages vaccination is administered, and whether or not coverage is complete.

New Vaccine Adoption in Lower-middle-income Countries

Lower-middle-income countries (LMICs) are lagging behind both high-income and low-income countries in new vaccine adoption. This study involved the following objectives: (1) understand the decision-making processes of LMICs on new vaccine adoption, (2) identify the factors influencing LMIC decisions, (3) obtain the views of vaccine manufacturers about LMIC markets for new vaccines, and (4) make recommendations concerning how to speed up and improve decision making, including proposing mechanisms for implementation of the recommendations,